Skip to main content
. 2024 Nov 4;110:105433. doi: 10.1016/j.ebiom.2024.105433

Table 4.

Associations of mosaicism with Alzheimer's Disease blood-based biomarkers for each of the cohorts.

Biomarkera ABC-DS (N = 309)
Legacy (N = 265)
Meta-analysis
Full trisomy (N = 286) Mosaic (N = 23) β(p) Full trisomy (N = 241) Mosaic (N = 24) β(p) β(p)
40
 Mean (SD) 450.5 (93) 412 (98.3) −51.6 (0.013) 332.7 (101.7) 295 (126.2) −31.21 (0.16) −42.19 (0.011)
 Range 60.9–759 187–617 28.8–703 94.9–640
42
 Mean (SD) 15.3 (3) 14.3 (3.3) −1.44 (0.027) 14.6 (5) 13.3 (5.5) −1.13 (0.30) −1.30 (0.038)
 Range 2.2–24.5 6.7–21.3 1.1–30.2 5.3–24.9
Tau
 Mean (SD) 2.7 (1.9) 2.7 (1.8) −0.04 (0.39) 3.3 (7.4) 3 (1.2) 0.08 (0.086) 0.02 (0.13)
 Range 0.13–18.4 0.18–9.8 0.6–115 1–6.2
NfL
 Mean (SD) 21.4 (20.1) 26.4 (24.8) −0.031 (0.51) 34.9 (31.6) 43.1 (27.7) 0.06 (0.26) 0.01 (0.34)
 Range 4.1–233 6.6–122 4.9–267 12.5–134

Only participants with data for the biomarkers were included. Models were adjusted for sex assigned at birth, age, dementia status, and level of premorbid intellectual disability. Tau and NfL linear models were calculated after log10 transformation of the biomarker data.

a

Pg/mL.